Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

NCT00693420 ↗

Phase 3 Completed 278 enrolled Allergan

RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.

Timeline

Start: 2007-04
Primary completion: 2007-10
Completion: 2007-12

Outcome

Met primary endpoint

paper By week 16, the bimatoprost group reported significantly greater improvements from baseline on all ESQ items (P ≤ .0433). PMID 23873891 ↗

paper The bimatoprost group reported significantly greater levels of positive patient outcomes and satisfaction than the vehicle group across all 23 questions and all 3 domains of the primary PRO questionnaire. PMID 23873891 ↗

Publications

Fagien S, Walt JG, Carruthers J, Cox SE, Wirta D, Weng E, Beddingfield FC 3rd. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study. Aesthet Surg J. 2013 Aug 1;33(6):789-98. doi: 10.1177/1090820X13495887. Epub 2013 Jul 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bimatoprost	Other / unclassified	0.03 %	Topical

Indications

No indication recorded.